Table 2.
Clinical and pathological characteristics in breast cancer patients with and without brown fat
| Brown fat + | Brown fat + | |
|---|---|---|
| Race |
|
|
| White |
7 (43.8) |
38 (47.5) |
| Black |
6 (37.5) |
39 (48.8) |
| Other |
3 (18.7) |
3 ( 3.7) |
| Tumor size (cm) |
3.26 ± 1.85 |
3.38 ± 1.74 |
| Tumor histology (%) |
|
|
| Ductal |
14 (87.5) |
59 (73.8) |
| Adeno |
0 (0.0) |
1 ( 1.3) |
| Lobular |
0 (0.0) |
9 (11.3) |
| Unknown |
2 (12.5) |
11 (13.7) |
| Nodal metastasis |
|
|
| Positive |
8 (50.0) |
32 (40.0) |
| Negative |
3 (18.8) |
17 (21.3) |
| Unknown |
5 (31.2) |
36 (45.0) |
| Distant metastasis |
|
|
| Positive |
8 (50.0) |
44 (55.0) |
| Negative |
8 (50.0) |
36 (45.0) |
| Stage |
|
|
| I |
0 |
4 ( 5.0) |
| II |
3 (18.8) |
15 (18.8) |
| III |
3 (18.8) |
9 (11.3) |
| IV |
10 (52.5) |
45 (56.3) |
| Unknown |
0 |
7 ( 8.7) |
| ER |
|
|
| Positive |
10 (62.5) |
42 (52.5) |
| Negative |
4 (25.0) |
27 (33.8) |
| Unknown |
2 (12.5) |
11 (13.8) |
| PR |
|
|
| Positive |
7 (43.8) |
36 (45.0) |
| Negative |
6 (37.5) |
33 (41.3) |
| Unknown |
3 (18.7) |
11 (13.7) |
| HER2 |
|
|
| Positive |
6 (37.5) |
12 (15.0) |
| Negative |
7 (43.8) |
54 (67.5) |
| Unknown |
3 (18.7) |
14 (17.5) |
| Grade |
|
|
| I |
0 |
4 ( 5.0) |
| II |
5 (31.3) |
15 (18.8) |
| III |
7 (43.8) |
28 (35.0) |
| Unknown | 4 (25.0) | 33 (41.2) |